## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -2.5% below STRENGTH zone (3.0-6.0%); PEG 2.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($286.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. How Chubb’s Dividend and Cyber Risk Findings Could Shape Chubb (CB) Investors’ Long-Term View**
- Source: Simply Wall Street | 20251204T160818 | Somewhat-Bullish | Relevance: 100%
- Chubb (CB) recently declared a quarterly dividend of US$0.97 per share and a survey by the company highlighted that cyber risk is the top perceived risk among affluent North Americans, yet only 41% have standalone cyber insurance. The article explores how these factors, coupled with Chubb's focus on specialized and international insurance lines, could influence the company's investment narrative and long-term positioning. Investors are encouraged to consider the balance between shareholder returns and investment in product areas like cyber insurance, especially amidst a softer property and casualty market.

**2. Chubb Limited (CB): A Bull Case Theory**
- Source: Insider Monkey | 20251204T141500 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Chubb Limited (CB), highlighting its undervaluation at 12x earnings with a 15% ROE. The company benefits from underwriting bespoke risks for elite clients, leading to high margins, robust investment income, and significant structural advantages. Despite potential volatility from catastrophes, Chubb's diversified risk pool, disciplined underwriting, and share buybacks position it for compounding book value and annual returns of 10-15%, with substantial upside if the market re-prices safety.

**3. Chubb EVP Ortega sells $1.28 million in shares**
- Source: Investing.com | 20251204T190031 | Neutral | Relevance: 100%
- Chubb Executive Vice President, Juan Luis Ortega, sold 4,357 common shares worth $1.28 million on December 2, 2025. Following the transaction, Ortega directly owns 36,092.93 shares. The company, which has a market capitalization of $116.13 billion and a P/E ratio of 12.21, is considered undervalued with "GREAT" financial health according to InvestingPro analysis.

**4. Chubb Limited $CB Shares Sold by M&T Bank Corp**
- Source: MarketBeat | 20251204T121027 | Neutral | Relevance: 100%
- M&T Bank Corp reduced its stake in Chubb Limited by 14.2% in Q2, now holding 87,670 shares valued at $25.4 million, while institutional investors own approximately 83.81% of the company. Chubb surpassed quarterly expectations with an EPS of $7.49 and revenue of $16.15 billion, exhibiting a 7.5% year-over-year revenue increase. Company insiders have sold 57,333 shares worth about $16.63 million in the last quarter, and Chubb declared a $0.97 per share quarterly dividend.

**5. Invesco Ltd. Has $653.54 Million Position in Chubb Limited $CB**
- Source: MarketBeat | 20251204T120806 | Somewhat-Bullish | Relevance: 100%
- Invesco Ltd. reduced its stake in Chubb Limited (NYSE:CB) by 1.9% in the second quarter, now holding 2,255,756 shares valued at approximately $653.54 million. Despite institutional selling, Chubb exceeded quarterly expectations with $7.49 EPS on $16.15 billion revenue and declared a quarterly dividend of $0.97. Analyst ratings for the stock currently average "Hold" with a target price of $308.32.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $300 | $295 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Heavy insider selling: $15M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.26 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $125.0B |
| Beta | 0.52 |
| 52W Range | $252.16 - $314.68 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.26 |
| Forward P/E | 11.2 |
| Current P/E | 12.5 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at -2.5% (minimal 5-day change). Below STRENGTH zone by 5.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.66), momentum weakening. RSI neutral at 57. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.46% (CS: 26) | Weak |
| RSI_14 | 57.3 | Neutral |
| MACD Histogram | -0.66 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.040x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $294.64
- **Stop Loss:** $286.26 (2.8% risk)
- **Target:** $303.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 119
- **Position Value:** $35,062.16
- **Portfolio %:** 35.06%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*